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Even though human Campylobacter jejuni infections are progressively increasing
worldwide, the underlying molecular mechanisms of pathogen-host-interactions are
still not fully understood. We have recently shown that the secreted serine protease
HtrA plays a key role in C. jejuni cellular invasion and transepithelial migration in
vitro, and is involved in the onset of intestinal pathology in murine infection models
in vivo. In the present study, we investigated whether the protease activity of HtrA
had an impact in C. jejuni induced acute enterocolitis. For this purpose, we perorally
infected secondary abiotic IL-10−/− mice with wildtype C. jejuni strain NCTC11168
(11168WT) or isogenic bacteria carrying protease-inactive HtrA with a single point
mutation at S197A in the active center (11168HtrA−S197A). Irrespective of the applied
pathogenic strain, mice harbored similar C. jejuni loads in their feces and exhibited
comparably severe macroscopic signs of acute enterocolitis at day 6 postinfection
(p.i.). Interestingly, the 11168HtrA−S197A infected mice displayed less pronounced colonic
apoptosis and immune cell responses, but enhanced epithelial proliferation as compared
to the 11168WT strain infected controls. Furthermore, less distinct microscopic sequelae
in 11168HtrA−S197A as compared to parental strain infected mice were accompanied
by less distinct colonic secretion of pro-inflammatory cytokines such as MCP-1, IL-6,
TNF, and IFN-γ in the former as compared to the latter. Strikingly, the S197A point
mutation was additionally associated with less pronounced systemic pro-inflammatory
immune responses as assessed in serum samples. In conclusion, HtrA is a remarkable
novel virulence determinant of C. jejuni, whose protease activity is not required for
intestinal colonization and establishment of disease, but aggravates campylobacteriosis
by triggering apoptosis and pro-inflammatory immune responses.
Keywords: Campylobacter jejuni, secondary abiotic IL-10−/− mice, serine protease activity, high-temperature
requirement A (HtrA), host-pathogen-interaction, intestinal immunopathology, extra-intestinal and systemic
immune responses, bacterial translocation
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INTRODUCTION
Campylobacter jejuni is a Gram-negative, spiral-shaped,
flagellated bacterium that grows under microaerobic conditions
at a temperature optimum of 37–42◦C (Parkhill et al., 2000;
Brøndsted et al., 2005; Young et al., 2007). C. jejuni is a
commensal in the gastrointestinal tract of various animal
hosts such as swine, cattle, and birds (Fouts et al., 2005).
Consequently, the consumption of contaminated meat products,
raw milk and water are the most frequent sources of C. jejuni
infections in humans (Bereswill et al., 2011; Pielsticker et al.,
2012). The infection comes along with abdominal pain, fever,
myalgia, and watery or bloody diarrhea. In the acute stage of
human campylobacteriosis, manifestations like crypt abscesses,
ulcerations, and accumulation of immune cells in the colon
can be observed (Kist and Bereswill, 2001; Backert et al., 2017).
In addition, post-infectious complications such as Guillain–
Barré syndrome and Miller Fisher syndrome can emerge in
a minority of patients (Masanta et al., 2013; Goodfellow and
Willison, 2016; Backert et al., 2017). C. jejuni bacteria enter the
host intestine via the oral route and colonize the distal ileum
and colon by attaching to epithelial cells (Kist and Bereswill,
2001; Boehm et al., 2018). To reach deeper tissues and cause
inflammatory responses during the infection process, C. jejuni
need to cross the epithelial barrier, which is accomplished by
paracellular transmigration as well as invasion into intestinal
epithelial cells (Boehm et al., 2012). After crossing the intestinal
epithelial barrier and invasion of the underlying submucosa,
C. jejuni can enter the mesenteric lymph nodes (MLN), and
may reach different organs such as the spleen or liver via the
bloodstream, thereby causing extra-intestinal inflammation
(Backert et al., 2013).
The exact mechanisms how C. jejuni induce acute and
invasive enterocolitis remain yet unclear. However, it has been
observed that C. jejuni interferes with several signal transduction
pathways of the innate immune system. We have recently
shown that the pattern recognition receptors Toll-like receptor-
4 (TLR-4) (Bereswill et al., 2011; Haag et al., 2012a; Otto
et al., 2012) and nucleotide-oligomerization-domain-2 (Nod2)
(Heimesaat et al., 2017a,b) play a pivotal role in the development
of immunopathology during C. jejuni infection. Moreover, C.
jejuni rapidly activates MAPK/ERK (mitogen-activated protein
kinases/extracellular signal-regulated kinases) as well as the pro-
inflammatory transcription factor NF-κB (nuclear factor kappa-
light-chain-enhancer of activated B cells) that up-regulates the
transcription of a variety of immune response genes (Chen et al.,
2006; Hu et al., 2006). It has been shown that C. jejuni can
Abbreviations: CBA, Cytometric Bead Array; CFU, colony-forming units; HtrA,
high-temperature requirement A; i.e., id est; IFN, interferon; IL, interleukin;
MAPK/ERK, mitogen-activated protein kinases/extracellular signal-regulated
kinases; MCP, Monocyte chemoattractant protein; MLN, mesenteric lymph
nodes; n.s., not significant; NF-κB, nuclear factor kappa-light-chain-enhancer
of activated B cells; Nod, nucleotide-oligomerization-domain; PBS, phosphate-
buffered saline; PDZ, post synaptic density protein (PSD59), Drosophila disc large
tumor suppressor (Dlg1), zonula occludens-1 protein (ZO-1); p, probability; p.i.,
postinfection; SPF, specific pathogen free; TLR, toll-like receptor; TNF, tumor
necrosis factor; WT, wildtype.
enhance the production of interleukin (IL)−8, a chemoattractant
that recruits dendritic cells, macrophages and neutrophils to the
site of infection (Jagusztyn-Krynicka et al., 2009). Internalization
of C. jejuni by dendritic cells results in their activation and
triggers adaptive immune response. This leads to an enhanced
expression of a variety of pro-inflammatory cytokines, namely
IL-1β, IL-6, IL-8, IL-10, IL-12, Interferon (IFN) -γ and tumor
necrosis factor (TNF) in immune cells (Hu et al., 2006; Jagusztyn-
Krynicka et al., 2009).
C. jejuni is known to express numerous virulence factors
for its adhesion to, invasion into and transmigration across gut
epithelial cells (Masanta et al., 2013). Recent studies suggest that
high-temperature requirement A (HtrA) has a major impact
on these processes and thereby increases virulence of several
pathogens (Boehm et al., 2012, 2018). So far, HtrA proteases
and their orthologs have been investigated in bacterial pathogens
such as Escherichia coli (Jiang et al., 2008; Krojer et al.,
2008), Helicobacter pylori (Hoy et al., 2010; Albrecht et al.,
2018), Legionella pneumophila (Schubert et al., 2015), Borrelia
burgdorferi (Coleman et al., 2013), Bacillus anthracis (Chitlaru
et al., 2011, 2017), Streptococcus pneumoniae (Cassone et al.,
2012) or defined Chlamydia species (Wu et al., 2011). Various
studies revealed distinct bacterial virulence features of HtrA
orthologs. For example, inactivation of HtrA in Clostridium
difficile resulted in more pronounced virulence as shown in a
hamster model (Bakker et al., 2014). In contrast, overexpression
of HtrA in Streptococcus pneumoniae was associated with
enhanced virulence of the pathogen in vitro, whereas the
inactivation of HtrA resulted in attenuated pneumonia in
infected mice (de Stoppelaar et al., 2013).
HtrA constitutes a serine protease with an additional
chaperone function, which provides a protective effect against
temperature- and oxidative stress induced protein degradation
in the periplasm (Krojer et al., 2008; Boehm et al., 2018).
The protein consists of a signal peptide, a trypsin-like serine
protease module and one or two PDZ (post synaptic density
protein (PSD59), Drosophila disc large tumor suppressor (Dlg1),
and zonula occludens-1 protein (ZO-1)) domains that enable
protein-protein interactions (Brøndsted et al., 2005; Backert
et al., 2018). Surprisingly, HtrA is not only acting intracellularly
within the bacteria, but is also actively secreted into the
extracellular environment, where it can degrade extracellular
host proteins like the cell surface adhesion protein and tumor-
suppressor E-cadherin (Boehm et al., 2012, 2013 Hoy et al.,
2012; Backert et al., 2013; Heimesaat et al., 2014a). Cleavage of
the extracellular E-cadherin domain leads to the depletion of
adherence junctions. The following downregulation of barrier
functions enables C. jejuni to transmigrate across the polarized
epithelium (Boehm et al., 2012; Hoy et al., 2012). In vitro
experiments revealed that deletion of the htrA gene or expression
of a HtrA protease activity-deficient point mutant variant (serine
residue 197 replaced by alanine) in C. jejuni leads to significantly
reduced E-cadherin cleavage and transmigration across polarized
epithelial cells, but did not cause loss of bacterial motility
(Boehm et al., 2013). The finding that the S197A point mutation
abolished protease activity, but did not affect HtrA secretion,
led to the assumption that HtrA secretion does not require
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proteolytic activity (Boehm et al., 2013). Recent studies in the
secondary abiotic IL-10−/− mouse model infected with a C.
jejuni htrA deletion mutant (111681htrA) showed notably less
severe clinical symptoms and reduced intestinal as well as extra-
intestinal immunopathological sequelae of infection as compared
to 11168WT strain infected control mice (Heimesaat et al., 2014a).
The role of HtrA during C. jejuni induced immunopathology
was further confirmed in conventional infant mice which showed
reduced intestinal and extra-intestinal (liver, kidney and lung)
immune responses after infection with the 111681htrA mutant
in comparison to 11168WT infection (Heimesaat et al., 2014b).
However, the role of HtrA’s protease activity in C. jejuni infected
mice was not yet investigated.
For a long time, investigations of distinct C. jejuni
pathogenicity factors in vivo have been hampered by the
scarcity of appropriate models (Masanta et al., 2013; Heimesaat
and Bereswill, 2015). Conventional mice, for instance, are
well protected from C. jejuni infection even upon peroral
challenge with high pathogenic loads due to the physiological
colonization resistance exerted by the murine commensal
gut microbiota (Bereswill et al., 2011; Fiebiger et al., 2016).
Following depletion of the intestinal microbiota by broad-
spectrum antibiotic treatment, however, secondary abitoic mice
can be stably infected with C. jejuni following peroral infection,
but do not display gross pathogen induced symptoms seen in
human campylobacteriosis (Bereswill et al., 2011). Given that
mice are approximately 1,000 times more resistant to TLR-4
ligands including lipopolysaccharide and lipooligosacchariade
and IL-10 gene deficiency renders mice susceptible to TLR-
4 ligands (Warren et al., 2010; Haag et al., 2012a), we could
recently show that upon depletion of the gut microbiota by
broad-spectrum antibiotic treatment, IL-10−/− mice could not
only be stably infected with high C. jejuni loads, but also
developed acute, non-self-limiting C. jejuni induced enterocolitis
within 1 week postinfection (p.i.), therebymimicking key features
of severe campylobacteriosis in immunocompromized patients
(Haag et al., 2012a; Heimesaat et al., 2014c, 2017a).
In order to investigate the role of C. jejuni HtrA protease
activity in vivo, we here infected secondary abiotic IL-
10−/− mice with the C. jejuni strain 11168HtrA−S197A which
expresses the protease activity-deficient point mutant variant and
used the corresponding 11168WT as reference. We addressed
bacterial colonization efficiencies and translocation rates to
extra-intestinal tissue sites and surveyed clinical symptoms
as well as intestinal and extra-intestinal including systemic
inflammatory immune responses following peroral infection
with respective strains.
MATERIALS AND METHODS
Generation of Secondary Abiotic Mice
Female and male IL-10−/− mice (all in C57BL/6j background)
were bred and maintained under specific pathogen free (SPF)
conditions in the same unit of the Forschungseinrichtungen für
Experimentelle Medizin (FEM, Charité - University Medicine
Berlin). To order to assure stable gastrointestinal C. jejuni
colonization and override physiological colonization resistance
(Bereswill et al., 2011), secondary abiotic (i.e., gnotobiotic)
mice virtually lacking an intestinal microbiota were generated
(Heimesaat et al., 2006; Bereswill et al., 2011; Haag et al.,
2012a). In brief, immediately post weaning 3 weeks old
mice were subjected to a 10-week course of broad-spectrum
antibiotic treatment by adding ampicillin plus sulbactam (1 g/L;
Ratiopharm, Germany), vancomycin (500 mg/L; Cell Pharm,
Germany), ciprofloxacin (200 mg/L; Bayer Vital, Germany),
imipenem (250 mg/L; MSD, Germany) and metronidazole (1
g/L; Fresenius, Germany) to the autoclaved drinking water (ad
libitum). To assure antibiotic washout, the antibiotic cocktail was
replaced by autoclaved tap water 2 days prior infection.
C. jejuni Infection
Mice (3 months of age) were then perorally infected with
109 colony forming units (CFU) of the C. jejuni parental
strain NCTC11168 (11168WT) or the isogenic mutant strain
11168HtrA−S197A of the serine protease gene htrA (Bæk et al.,
2011) in a volume of 0.3mL phosphate buffered saline (PBS;
Gibco, life technologies, UK) on two consecutive days (days
0 and 1) by gavage as reported previously (Bereswill et al.,
2011). Animals were continuously maintained in a sterile
environment (autoclaved food and drinking water or sterile
antibiotic cocktail) and handled under strict aseptic conditions
to prevent from contaminations.
Clinical Conditions
Before and after C. jejuni infection the clinical conditions of mice
were assessed on a daily basis by using a standardized cumulative
clinical score (maximum 12 points), addressing the abundance of
blood in feces (0: no blood; 2: microscopic detection of blood by
the Guajac method using Haemoccult, Beckman Coulter / PCD,
Germany; 4: macroscopic blood visible), diarrhea (0: formed
feces; 2: pasty feces; 4: liquid feces), and the clinical aspect
(0: normal; 2: ruﬄed fur, less locomotion; 4: isolation, severely
compromised locomotion, pre-final aspect) as described earlier
(Heimesaat et al., 2014a).
Sampling Procedures
At day 6 p.i., mice were sacrificed by isoflurane inhalation
(Abbott, Germany). Luminal gastrointestinal samples (i.e., from
stomach, duodenum, ileum and colon) and ex vivo biopsies from
colon, MLN, liver, kidney, and spleen were taken under sterile
conditions. Large intestinal samples were collected from each
mouse in parallel for microbiological, immunohistopathological
and immunological analyses. The absolute colonic lengths were
measured by a ruler (in cm).
Immunohistochemistry
In situ immunohistochemical analyses were performed in
colonic ex vivo biopsies that had been immediately fixed in
5% formalin and embedded in paraffin as described earlier
(Alutis et al., 2015a,b; Heimesaat et al., 2018). In brief, in
order to detect apoptotic epithelial cells, proliferating epithelial
cells, macrophages/monocytes, T lymphocytes and regulatory
T cells, colonic paraffin sections (5µm) were stained with
primary antibodies directed against cleaved caspase 3 (Asp175,
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Cell Signaling, Beverly, MA, USA, 1:200), Ki67 (TEC3, Dako,
Denmark, 1:100), F4/80 (# 14-4801, clone BM8, eBioscience, San
Diego, CA, USA, 1:50), CD3 (#N1580, Dako, 1:10), and FOXP3
(FJK-16s, eBioscience, 1:100), respectively. Positively stained cells
were then examined by light microscopy (magnification 100 x
and 400 x), and for each mouse the average number of respective
positively stained cells was determined within at least six high
power fields (HPF, 0.287 mm2, 400×magnification) by a blinded
independent investigator.
Bacterial Colonization
C. jejuniwere quantitatively assessed in feces over time p.i. and in
homogenates of ex vivo biopsies taken from MLN, spleen, liver,
and kidney at day 6 p.i. by culture as stated elsewhere (Bereswill
et al., 2011; Heimesaat et al., 2013). The detection limit of viable
pathogens was≈100 CFU per g.
Cytokine Detection in Supernatants of
Intestinal and Extra-Intestinal ex vivo
Biopsies
Colonic ex vivo biopsies were cut longitudinally, washed in PBS,
and strips of approximately 1 cm2 tissue were placed in 24-
flat-bottom well culture plates (Nunc, Germany) containing 500
µL serum-free RPMI 1640 medium (Gibco, life technologies,
UK) supplemented with penicillin (100 U/mL) and streptomycin
(100µg/mL; PAA Laboratories, Germany). After 18 h at 37◦C,
culture supernatants were tested for MCP-1, IL-6, TNF, and
IFN-γ by the Mouse Inflammation Cytometric Bead Assay
(CBA; BD Biosciences, Germany) on a BD FACSCanto II
flow cytometer (BD Biosciences). Systemic pro-inflammatory
cytokine concentrations were measured in serum samples.
Statistical Analysis
Medians and levels of significance were determined using Mann-
Whitney test (GraphPad Prism v7, USA) as indicated. Two-
sided probability (p) values ≤ 0.05 were considered significant.
Experiments were reproduced three times.
RESULTS
Intestinal Colonization Properties of a C.
jejuni 11168HtrA-S197A Mutant Strain in
Perorally Infected Secondary Abiotic
IL-10−/− Mice
To assure stable C. jejuni infection, the gut microbiota and
hence physiological colonization resistance of IL-10−/− mice
was abrogated by standard procedures using a ten-week course
of broad-spectrum antibiotic treatment (Bereswill et al., 2011;
Heimesaat et al., 2014a,b). Subsequently, generated secondary
abiotic mice were subjected to peroral challenge with 109 CFU of
either the parentalC. jejuni strain 11168WT or its isogenic mutant
11168HtrA−S197A variant. Our daily survey of fecal pathogen
concentrations revealed that the point mutation in the htrA gene
did not impact intestinal colonization properties as indicated
by comparable median loads of 109 CFU of either C. jejuni
strain per g feces until day 6 p.i. (Figure 1). Upon sacrifice,
FIGURE 1 | Time course of fecal C. jejuni loads following peroral infection of
secondary abiotic IL-10−/− mice. Secondary abiotic IL-10−/− mice were
perorally infected either with the C. jejuni 11168WT strain [(A), closed circles]
or the isogenic htrA mutant 11168HtrA−S197A [(B), open circles] by gavage on
two consecutive days (d) 0 and 1. Pathogenic loads were quantitated in fecal
samples derived from each mouse on a daily basis post-infection by culture
and expressed in colony forming units per g (CFU/g). Medians (black bars) and
numbers of analyzed animals (in parentheses) are indicated. Data were pooled
from four independent experiments.
the 11168HtrA−S197A mutant strain infected mice harbored
lower C. jejuni numbers in luminal samples taken from the
stomach, duodenum and colon as compared to 11168WT infected
counterparts (p < 0.05–0.001; Figure 2). Of note, the differences
in C. jejuni loads were less pronounced the more distal the
gastrointestinal compartment the samples were derived from.
Particularly in the colonic lumen the differences in median
pathogen loads were approximately 0.5 orders of magnitude and
hence rather minor (p< 0.05; Figure 2D).
Macroscopic Sequelae in C. jejuni
11168HtrA-S197A Infected Secondary Abiotic
IL-10−/− Mice
We further assessed whether the disease development upon
peroral infection of secondary abiotic IL-10−/− mice differed
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FIGURE 2 | C. jejuni loads in the gastrointestinal tract of secondary abiotic IL-10−/− mice six days following peroral infection. Secondary abiotic IL-10−/− mice were
perorally infected either with the C. jejuni 11168WT strain (closed circles) or the isogenic htrA mutant 11168HtrA−S197A (open circles) by gavage on days 0 and 1.
Pathogenic loads (CFU, colony forming units per gram) were assessed in luminal samples derived from distinct parts of the gastrointestinal tract (A–D) at day 6
postinfection as indicated by culture. Naive mice (open diamonds) served as uninfected controls. Medians (black bars), levels of significance (p-values) determined by
the Mann-Whitney U-test and numbers of analyzed animals (in parentheses) are indicated. Data were pooled from four independent experiments.
between 11168HtrA−S197A mutant and 11168WT strains. Until
day 6 following infection with either strain, mice were suffering
from comparably severe C. jejuni induced disease as indicated
by similar clinical scores that had been assessed during our
kinetic survey (Figure 3A and Figure S1). We further stratified
clinical conditions of C. jejuni infected mice to fecal blood
positivity rates and determined virtually comparably frequent
abundances of fecal blood following infection with either C.
jejuni strain (Figure S2). Given that intestinal inflammation is
accompanied by significant shortening of the inflamed intestine
(Heimesaat et al., 2006, 2007; Haag et al., 2012a,b), we measured
the large intestinal lengths upon necropsy. At day 6 p.i., colonic
lengths of mice infected with either strain were comparable
(n.s. Figure 3B), but lower as compared to uninfected naive
control animals as expected (p < 0.001; Figure 3B). Hence,
the loss of proteolytic activity of HtrA caused by the S197A
point mutation in the htrA gene did neither impact pathogenic
intestinal colonization properties nor gross disease following
peroral C. jejuni infection of secondary abiotic IL-10−/− mice.
Intestinal Histopathology and Inflammatory
Responses in C. jejuni 11168HtrA-S197A
Infected Secondary Abiotic IL-10−/− Mice
We next surveyed inflammatory sequelae of C. jejuni infection
histologically. At day 6 p.i., mice infected with either strain
exhibited multi-fold increased numbers of apoptotic epithelial
cells as compared to uninfected counterparts (p < 0.001 vs.
naive; Figure 4A and Figure S3A). This increase was, however,
less pronounced in mice infected with the 11168HtrA−S197A
mutant as compared to the 11168WT infected animals (p < 0.01;
Figure 4A and Figure S3A), given that the former displayed
approximately 50% of caspase3 positive colonic epithelial
cells as compared to the latter (Figure 4A and Figure S3A).
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FIGURE 3 | Macroscopic sequelae in C. jejuni infected secondary abiotic IL-10−/− mice. Secondary abiotic IL-10−/− mice were perorally infected either with the C.
jejuni 11168WT strain (closed circles) or the isogenic htrA mutant 11168HtrA−S197A (open circles) by gavage on days 0 and 1. (A) Clinical symptoms were
quantitatively assessed applying a standardized clinical scoring system on day 6 postinfection (see methods) and (B) colonic lengths were measured by a ruler (in cm).
Naive mice (open diamonds) served as uninfected controls. Medians (black bars), level of significance (p-values) as determined by Mann-Whitney U-test and numbers
of analyzed animals (in parentheses) are indicated. Data were pooled from four independent experiments.
Furthermore, C. jejuni infection resulted in increased numbers
of Ki67 positive colonic epithelial cells indicative for enhanced
cell proliferation and regeneration (p<0.001 vs. naive; Figure 4B
and Figure S3B). Conversely to the caspase3 positive cells,
11168HtrA−S197A infected mice displayed slightly higher Ki67
positive cells in the large intestinal epithelium as compared to
11168WT strain infected counterparts at day 6 p.i. (Figure 4B
and Figure S3B).
We further assessed innate (such as F4/80 positive
macrophages and monocytes) and adaptive (including CD3
positive T lymphocytes and FOXP3 positive regulatory T
cells) immune responses upon C. jejuni infection. At day
6 p.i., increased cell numbers of both adaptive and innate
immunity parameters could be detected in the mucosa and
lamina propria of infected mice irrespective of the applied
C. jejuni strain (Figure 5 and Figure S3). In the colon of
11168HtrA−S197A infected mice, however, lower numbers of
F4/80 positive and FOXP3 positive cells could be determined
as compared to 11168WT infected control mice (p < 0.05;
Figures 5A,C and Figures S3C,E). Hence, the protease-inactive
htrA point mutant C. jejuni strain caused less pronounced
colonic apoptosis and immune cell responses, but enhanced
epithelial proliferation upon peroral infection of secondary
abiotic IL-10−/− mice.
Colonic and Systemic Pro-Inflammatory
Cytokine Production in C. jejuni
11168HtrA-S197A Infected Secondary Abiotic
IL-10−/− Mice
We next surveyed pro-inflammatory cytokine concentrations
upon infection with respective C. jejuni strains in colonic ex vivo
biopsies (Figure 6). Six days following peroral challenge, large
intestinal MCP-1 concentrations induced by the 11168HtrA−S197A
strain were lower as compared to those in mice infected with
C. jejuni 11168WT(p < 0.05 vs. naive; Figure 6A). In addition,
C. jejuni infection with either strain resulted in elevated colonic
IL-6, TNF and IFN-γ secretion, whereas a trend toward lower
IL-6 concentrations could be assessed in the large intestines
of 11168HtrA−S197A as compared to 11168WT strain infected
mice at day 6 p.i. (n.s.; Figure 6B). Strikingly, strain-dependent
pro-inflammatory cytokine secretion was not restricted to the
gut, given that pro-inflammatory cytokines such as MCP-1,
IL-6, TNF, and IFN-γ in serum samples taken at day 6 p.i.
were lower in mice infected with the 11168HtrA−S197A strain
as compared to mice challenged with C. jejuni 11168WT (p <
0.05–0.01; Figure 7).
We further addressed whether the lowered immune responses
observed in mice challenged with the 11168HtrA−S197A mutant
had a consequence for transepithelial migration and subsequent
spread of viable C. jejuni from the intestinal tract to extra-
intestinal including systemic compartments. Notably, at day 6
p.i., C. jejuni could be cultured from 40% and 75% of MLN
taken from 11168WT and 11168HtrA−S197A strain infected mice,
respectively (Figure S4). Furthermore, viable C. jejuni could be
isolated from extra-intestinal and systemic compartments such
as liver, kidney, spleen and cardiac blood in single cases only
(Figure S4). Interestingly, in 14.3% of 11168HtrA−S197A strain
infected mice, but none of 11168WT samples, viable pathogens
were detectable in cardiac blood (Figure S4). Hence, the C.
jejuni 11168HtrA−S197A strain translocated with higher efficiency
possibly as a result of less distinct intestinal, but also less
pronounced systemic pro-inflammatory cytokine secretion as
compared to the 11168WT strain.
Taken together, investigation of the 11168HtrA−S197A mutant
strain in the secondary abiotic IL-10−/− mice infection model
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FIGURE 4 | Microscopic colonic sequelae in C. jejuni infected secondary abiotic IL-10−/− mice. Secondary abiotic IL-10−/− mice were perorally infected either with
the C. jejuni 11168WT strain (closed circles) or the isogenic htrA mutant 11168HtrA−S197A (open circles) by gavage on days 0 and 1. The average numbers of colonic
epithelial (A) apoptotic cells (positive for caspase-3, Casp3) and (B) proliferating/regenerating cells (positive for Ki67) from six high power fields (HPF, 400x
magnification) per animal were assessed microscopically in immunohistochemically stained large intestinal paraffin sections at day 6 postinfection. Naive mice (open
diamonds) served as uninfected controls. Medians (black bars), levels of significance (p-values) determined by the Mann-Whitney U-test and numbers of analyzed
animals (in parentheses) are indicated. Data were pooled from four independent experiments.
FIGURE 5 | Colonic immune cell responses in C. jejuni infected secondary abiotic IL-10−/− mice. Secondary abiotic IL-10−/− mice were perorally infected either
with the C. jejuni 11168HtrA−S197A strain (closed circles) or the isogenic htrA mutant 11168HtrA−S197A (open circles) by gavage on days 0 and 1. At day 6
postinfection, the average numbers of colonic epithelial of colonic (A) macrophages and monocytes (positive for F4/80), (B) T lymphocytes (positive for CD3), and (C)
regulatory T cells (positive for FOXP3) were assessed microscopically from six high power fields (HPF, 400x magnification) per animal in immunohistochemically
stained large intestinal paraffin sections. Naive mice (open diamonds) served as uninfected controls. Medians (black bars), levels of significance (p-values) determined
by the Mann-Whitney U-test and numbers of analyzed animals (in parentheses) are indicated. Data were pooled from four independent experiments.
revealed that the protease activity of C. jejuni HtrA is not
required for intestinal colonization and establishment of disease,
but triggers apoptosis and pro-inflammatory immune responses
in the intestines as well as in systemic compartments. It is of note
that the proteolytic activity of HtrA limits bacterial translocation
to MLN and thus protects the host against systemic spread
of C. jejuni.
DISCUSSION
The serine protease and chaperoneHtrA constitutes a remarkable
virulence factor that enables C. jejuni to transmigrate across
polarized epithelial cells by cleavage of E-cadherin and probably
other junctional proteins (Boehm et al., 2012, 2018; Hoy
et al., 2012). HtrA chaperone activity seems to be crucial for
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FIGURE 6 | Colonic secretion of pro-inflammatory cytokines in C. jejuni infected secondary abiotic IL-10−/− mice. Secondary abiotic IL-10−/− mice were perorally
infected either with the C. jejuni 11168HtrA−S197A strain (closed circles) or the isogenic htrA mutant 11168HtrA−S197A (open circles) by gavage on days 0 and 1. (A)
MCP-1, (B) IL-6, (C) TNF, and (D) IFN-γ concentrations were measured in supernatants derived from colonic ex vivo biopsies at day 6 postinfection. Naive mice (open
diamonds) served as uninfected controls. Medians (black bars), levels of significance (p-value) determined by the Mann-Whitney U-test and numbers of analyzed
animals (in parentheses) are indicated. Data representative for four independent experiments are shown.
C. jejuni adherence to epithelial host cells and subsequently
invasion, whereby HtrA protease activity appears to be not
essential for these processes (Bæk et al., 2011). We have
recently shown in infected mice, that the serine protease HtrA
is not required for induction of enterocolitis by C. jejuni
per se and plays a role in the modulation of apoptosis and
immunopathology during campylobacteriosis (Heimesaat et al.,
2014a,b). Six days after infection with the C. jejuni 1htrA
deletion mutant, secondary abiotic IL-10−/− mice were suffering
from less severe C. jejuni induced symptoms and developed
less pronounced intestinal as well as extra-intestinal including
systemic pro-inflammatory immune responses upon infection
as compared to 11168WT strain infected control mice suffering
from acute enterocolitis (Heimesaat et al., 2014a,b). In order
to unravel in particular the role of the protease activity of
HtrA in colonization efficiency, clinical symptoms as well as
intestinal and extra-intestinal inflammation in more detail, we
analyzed the C. jejuni 11168HtrA−S197A point mutant variant
in secondary abiotic IL-10−/− mice in the present study. This
mutant lacks protease activity, but still retains the chaprone
function (Bæk et al., 2011; Boehm et al., 2012). Six days
following peroral infection, mice harbored comparable pathogen
loads of the mutant strain 11168HtrA−S197A or the parental
11168WT strain. Hence, inactivation of the serine protease active
site did not alter colonic colonization capacity of C. jejuni.
This supports the findings of Bæk and co-workers that the
periplasmic chaperone activity of HtrA is more important for
efficient binding to epithelial host cells than its protease activity
(Bæk et al., 2011). More importantly, in vitro studies revealed
that the protease-deficient S197A point mutant is incapable of
transmigrating across polarized epithelial cells (Boehm et al.,
2012). These findings led to the hypothesis, that the mutant
expressing the 11168HtrA−S197A variant would rather not induce
intestinal immunopathology of campylobacteriosis. However,
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FIGURE 7 | Systemic secretion of pro-inflammatory cytokines in C. jejuni infected secondary abiotic IL-10−/− mice. Secondary abiotic IL-10−/− mice were perorally
infected either with the C. jejuni 11168HtrA−S197A strain (closed circles) or the isogenic htrA mutant 11168HtrA−S197A (open circles) by gavage on days 0 and 1. (A)
MCP-1, (B) IL-6, (C) TNF, and (D) IFN-γ concentrations were measured in serum samples taken at day 6 postinfection. Naive mice (open diamonds) served as
uninfected controls. Medians (black bars), levels of significance (p-value) determined by the Mann-Whitney U-test and numbers of analyzed animals (in parentheses)
are indicated. Data representative for four independent experiments are shown.
our present in vivo study revealed that secondary abiotic IL-
10−/− mice infected with the 11168HtrA−S197A strain did in
fact develop ulcerative enterocolitis, which was characterized by
bloody diarrhea and wasting symptoms and were comparable
to the symptoms observed following 11168WT strain infection.
This observation is surprising and suggests that in addition
to HtrA other yet unknown bacterial factors contribute to
transepithelial migration of C. jejuni and disease development
in mice.
Interestingly, mice infected with the C. jejuni 11168HtrA−S197A
strain displayed less immunopathological sequelae within
the intestinal tract including colonic epithelial apoptosis
when compared to the 11168WT strain infected mice,
which is in contrast to the macroscopic phenotype that was
similar in 11168WT strain infection. One needs to take into
consideration, however, that the macroscopic aspect (i.e., the
clinical symptoms) of the mice are rather the sum of many
different pathophysiological sequelae from C. jejuni infection
and cannot only be attributed to the immune responses and
immunopathological features observed microscopically in
the intestinal mucosa. In fact, cell proliferative and hence
regenerative measures observed in colonic epithelia, thus
counteracting C. jejuni induced cell damage including colonic
epithelial apoptosis, were more pronounced in C. jejuni
11168HtrA−S197A strain as compared to parental strain infected
mice. Thus, protease activity of HtrA triggers colonic apoptosis,
but dampens cell proliferation required for tissue regeneration.
Similar results were obtained in our previous analysis of
the htrA deletion mutant 1htrA (Heimesaat et al., 2014a,b),
which further supports that the protease activity of HtrA
rather inhibits regeneration of damaged tissue and thereby
further aggravates intestinal inflammation. This let us to
propose that secreted HtrA might target immunoregulatory
factor(s) directly, and future experiments should address
this hypothesis. The idea that the protease activity of HtrA
triggers inflammatory processes in host cells is further
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underlined by lower numbers of immune cells at the site of
infection and less secretion of pro-inflammatory cytokines
in intestinal, but also extra-intestinal and, remarkably, even
systemic compartments following C. jejuni 11168HtrA−S197A
as compared to 11168WT strain infection as shown here and
in our previous studies with the C. jejuni 1htrA mutant vs.
parental strain (Heimesaat et al., 2014a,b). Of note, immune
responses triggered by the protease activity of HtrA prevented
translocation of viable pathogens from the intestinal lumen
to MLN and possibly to extra-intestinal including systemic
compartments. However, on the systemic level live bacteria
could be isolated, if at all, in single case only, irrespective of the
applied strain.
Taken together, our data demonstrate that the proteolytic
activity of HtrA results in the amplification of host immune
responses upon C. jejuni infection of mice, but is not required
for the onset and establishment of intestinal disease. Future
studies will unravel if further distinct domains within the HtrA
protein might have functional immunopathological implications
during campylobacteriosis.
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Figure S1 | Kinetic survey of clinical conditions in C. jejuni infected secondary
abiotic IL-10−/− mice. Secondary abiotic IL-10−/− mice were perorally infected
either with the C. jejuni 11168WT strain (A, closed circles) or the isogenic htrA
mutant 11168HtrA−S197A (B, open circles) by gavage on day (d) 0 and d1. Clinical
symptoms were quantitatively assessed applying a standardized clinical scoring
system from d0 until d6 postinfection (see methods). Medians (black bars) and
numbers of analyzed mice (in parentheses) are indicated. Data were pooled from
four independent experiments.
Figure S2 | Kinetic survey of fecal blood in C. jejuni infected secondary abiotic
IL-10−/− mice. Secondary abiotic IL-10−/− mice were perorally infected either
with the C. jejuni 11168WT strain (A, black bars) or the isogenic htrA mutant
11168HtrA−S197A (B, white bars) by gavage on days (d) 0 and 1. The cumulative
relative abundance of fecal blood (fecal blood+) out of four independent
experiments was assessed macroscopically and microscopically (in %). The
numbers of fecal blood positive mice out of the total numbers of analyzed animals
are given in parentheses at defined time points.
Figure S3 | Representative photomicrographs illustrating apoptotic and
proliferating epithelial as well as immune cells responses in large intestines of C.
jejuni infected secondary abiotic IL-10−/− mice. Secondary abiotic IL-10−/−
mice were perorally infected either with the strain C. jejuni 11168WT or the
isogenic htrA mutant 11168HtrA−S197A by gavage on days 0 and 1. Naive mice
served as uninfected controls. Photomicrographs representative for four
independent experiments illustrate the average numbers of (A) apoptotic epithelial
cells (Casp3+), (B) proliferating epithelial cells, (C) macrophages and monocytes
(F4/80+), (D) T lymphocytes (CD3+), and (E) regulatory T cells (FOXP3+) in at
least six high power fields (HPF) as quantitatively assessed in colonic paraffin
sections applying in situ immunohistochemistry at day 6 postinfection (100 ×
magnification, scale bar 100µm).
Figure S4 | Bacterial translocation in C. jejuni infected secondary abiotic
IL-10−/− mice. Secondary abiotic IL-10−/− mice were perorally infected either
with the C. jejuni strain 11168WT (black bars) or the isogenic htrA mutant
11168HtrA−S197A (open bars) by gavage on days 0 and 1. At day 6 postinfection,
pathogenic loads were quantitatively assessed in ex vivo biopsies derived from (A)
MLN, (B) liver, (C) kidney, (D) spleen and (E) cardiac blood by culture. The
cumulative relative translocation rate of viable pathogens into the respective
compartment out of four independent experiments is indicated (in %).
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